Literature DB >> 17512963

Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits.

Shih-Ming Chen1, Mei-Yu Fan, Chia-Chi Tseng, Yih Ho, Kuang-Yang Hsu.   

Abstract

Aristolochic acids (AAs) which exist in plants of the genus Aristolochia are the toxins responsible for aristolochic acid nephropathy (AAN). To investigate the pharmacokinetics and nephrotoxicity of AAs, rabbits were used in this study. The plasma concentrations of the main components of AAs, aristolochic acid I (AA I) and aristolochic acid II (AA II), were determined by a validated high-performance liquid chromatographic method. After intravenous administration of different doses (0.25, 0.5, 1.0, and 2.0mg/kg) of aristolochic acid sodium (AANa) to 4 respective groups of rabbits (n=6 for each dose), linear relationships between the doses of AA I and AA II and the area under the plasma concentration curve (AUC) were found to exist (p<0.001). AANa was also given in escalating doses (0.5, 1.0, and 2.0mg/kg) to the same rabbits at 7-day intervals. The clearance rates of both AA I and AA II significantly decreased with the escalating dose (p<0.001). A nonlinear relationship between the dose and AUC was obtained. Kidney specimens of rabbits were obtained to observe morphological changes on days 1 and 7 after AANa administration. The renal lesions caused by AAs consisted of progressive and dose-dependent tubular damage. However, no remarkable changes in the morphology of glomeruli were observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512963     DOI: 10.1016/j.toxicon.2007.03.011

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  5 in total

1.  Activation of p53 promotes renal injury in acute aristolochic acid nephropathy.

Authors:  Li Zhou; Ping Fu; Xiao R Huang; Fei Liu; Kar Neng Lai; Hui Y Lan
Journal:  J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 10.121

2.  Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy.

Authors:  Chiao-Shih Tseng; Shih-Ming Chen; Shu-Chen Chien; Kuang-Yang Hsu
Journal:  Adv Pharmacol Sci       Date:  2011-06-16

3.  Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.

Authors:  Travis Bui-Klimke; Felicia Wu
Journal:  Risk Anal       Date:  2014-06-20       Impact factor: 4.000

4.  Comparative studies on the multi-component pharmacokinetics of Aristolochiae Fructus and honey-fried Aristolochiae Fructus extracts after oral administration in rats.

Authors:  Jinbin Yuan; Gang Ren; Jian Liang; Chong-Zhi Wang; Zhihong Yan; Qun Huang; Jiankang Li; Yang Chen; Yi Tang; Xiaofei Liu; Chun-Su Yuan
Journal:  BMC Complement Altern Med       Date:  2017-02-10       Impact factor: 3.659

5.  The safety of Homnawakod herbal formula containing Aristolochia tagala Cham. in Wistar rats.

Authors:  Pinpat Tripatara; Winita Onlamul; Suksalin Booranasubkajorn; Jantanee Wattanarangsan; Sukit Huabprasert; Natchagorn Lumlerdkij; Pravit Akarasereenont; Tawee Laohapand
Journal:  BMC Complement Altern Med       Date:  2012-10-03       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.